P-26 EPIGENETIC MARKS IN PATIENTS WITH SUSTAINED VIRAL RESPONSE TO HCV AND RESIDUAL LIVER FIBROSIS ARE RESTORED BY PROLONGED-RELEASE PIRFENIDONE

P-26 EPIGENETIC MARKS IN PATIENTS WITH SUSTAINED VIRAL RESPONSE TO HCV AND RESIDUAL LIVER FIBROSIS ARE RESTORED BY PROLONGED-RELEASE PIRFENIDONE

Conflict of interest: No Introduction and Objectives: Patients with residual liver fibrosis following the eradication of hepatitis C virus (HCV) represent a significant clinical challenge due to the continuous risk of disease progression and the development of hepatocellular carcinoma. This study ai...

Full description

Saved in:
Bibliographic Details
Main Authors: Eira Cerda Reyes, Ricardo De la Rosa Bibiano, Ana Sandoval Rodriguez, Rebeca Rosas Campos, Rebeca Escutia Gutiérrez, Ángel Omar Vázquez Esqueda, Stefanny Cornejo Hernández, Alejandro Gutiérrez Átemis, Salvador Amezquita Pérez, Jorge Luis Poo, Gildardo Agustin Garrio Sanchez, Juan Ramón Aguilar, Juan Armendáriz Borunda
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:Annals of Hepatology
Online Access:http://www.sciencedirect.com/science/article/pii/S166526812400423X
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S166526812400423X

Similar Items